Skip to main content

Want a detailed portfolio tracker?

Xencor (XNCR) P/E (2014 - 2026)

Xencor (XNCR) P/E from Jun 30, 2014 to Jul 20, 2026. The TTM Xencor (XNCR) P/E is -8.00. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Xencor (XNCR)

YearP/EChange
2026-8.00-32.56%
2025-11.87+72.68%
2024-6.87-36.25%
2023-10.78-121.11%
202251.07+77.76%
202128.73-179.60%
2020-36.09-150.78%
201971.07-347.83%
2018-28.68-31.40%
2017-41.80-257.21%
201626.59-179.20%
2015-33.57-24.49%
2014-44.46N/A

Comparison Xencor (XNCR) P/E with competitors

Xencor (XNCR) P/E is -8.00.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.93%
FGENFibroGen Inc0.24-103.00%
CHRSCoherus Biosciences Inc0.85-110.60%
FBIOFortress Biotech Inc0.95-111.86%
ORMPOramed Pharmaceuticals Inc1.50-118.78%
AGENAgenus Inc3.01-137.60%
INVAInnoviva Inc3.15-139.40%
VXRTVaxart Inc3.55-144.35%
CRMDCorMedix Inc3.63-145.33%
CVACCureVac N.V.4.45-155.54%
GLPGGalapagos NV4.86-160.70%
SRPTSarepta Therapeutics Inc4.88-160.99%
ABEOAbeona Therapeutics Inc5.39-167.30%
ABUSArbutus Biopharma Corp5.60-169.90%
ZVRAZevra Therapeutics Inc5.89-173.55%
SPROSpero Therapeutics Inc6.23-177.81%
CGENCompugen Ltd6.31-178.88%
RIGLRigel Pharmaceuticals6.87-185.85%
SLXNSilexion Therapeutics Corp7.30-191.15%
OMEROmeros Corporation9.26-215.67%
AUPHAurinia Pharmaceuticals Inc9.58-219.74%
PLXProtalix BioTherapeutics Inc10.89-236.06%
ACADAcadia Pharmaceuticals Inc11.73-246.52%
TBPHTheravance Biopharma Inc12.26-253.19%
ADMAAdma Biologics Inc12.42-255.14%
HRMYHarmony Biosciences Holdings Inc13.82-272.65%
SABSSAB Biotherapeutics Inc14.14-276.60%
NAGENiagen Bioscience Inc14.82-285.12%
INCYIncyte Corp15.82-297.67%
REGNRegeneron Pharmaceuticals Inc15.86-298.09%
PBYIPuma Biotechnology Inc17.32-316.32%
CPRXCatalyst Pharmaceuticals Inc17.44-317.87%
EXELExelixis Inc17.54-319.10%
TGTXTG Therapeutics Inc18.97-336.94%
MDXGMimedx Group Inc20.55-356.76%
XOMAXOMA Royalty Corp22.87-385.78%
ARGXArgen X SE24.30-403.56%
CTMXCytomX Therapeutics Inc24.82-410.09%
HALOHalozyme Therapeutics Inc25.62-420.12%
VRTXVertex Pharmaceuticals Inc27.99-449.74%
RPRXRoyalty Pharma plc - Class A28.69-458.40%
SLNOSoleno Therapeutics Inc29.02-462.49%
ASNDAscendis Pharma A/S30.09-475.86%
LGNDLigand Pharmaceuticals Inc - Class B37.91-573.64%
APLSApellis Pharmaceuticals Inc39.02-587.50%
BMRNBiomarin Pharmaceutical Inc42.21-627.36%
KRYSKrystal Biotech Inc45.34-666.48%
ONCBeiGene Ltd69.54-968.78%
PHARPharming Group N.V.75.03-1037.31%
TECHBio-Techne Corp101.96-1373.78%
VCELVericel Corp109.92-1473.26%
ALNYAlnylam Pharmaceuticals Inc117.96-1573.76%
GMABGenmab140.29-1852.67%
TLXTelix Pharmaceuticals Ltd162.15-2125.80%
CORTCorcept Therapeutics Inc212.86-2759.26%